Coastlands Capital LP - 27 May 2026 Form 4 Insider Report for Eloxx Pharmaceuticals, Inc. (ELOX)

Reporting relationship: 10%+ Owner
Issuer ticker: ELOX
Reported as of: 27 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 May 2026, 21:55:45 UTC
Prior SEC filing: 01 May 2026
Next SEC filing: 22 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP

Key filing fact

Coastlands Capital LP filed Form 4 for Eloxx Pharmaceuticals, Inc. (ELOX) on 29 May 2026.

Key facts

This page summarizes Coastlands Capital LP's Form 4 filing for Eloxx Pharmaceuticals, Inc. (ELOX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 29 May 2026, 21:55.

Change

Previous filing in this sequence was filed on 01 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002068530 Primary reporting owner

Coastlands Capital LP

Relationship: 10%+ Owner
Address: 601 CALIFORNIA STREET, SUITE 1210, SAN FRANCISCO
Signature: /s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP
Signature date: 29 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELOX transaction

Common Stock

Other

Transaction value
Shares: -1,250,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 May 2026
Ownership: By Coastlands Capital LP
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELOX transaction Derivative

Pre-funded Warrant

Other

Transaction value
Shares: +1,250,000
Change %: +4.3%
Price: $0.000000^*
Shares after: 30,612,243
Date: 27 May 2026
Ownership: By Coastlands Capital LP
Underlying class: Common Stock
Underlying amount: 1,250,000
Exercise price: $0.0100
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Coastlands Capital LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Pursuant to the terms of that certain Amended and Restated Pre-Funded Warrant to Purchase Common Stock, dated as of April 27, 2026, Coastlands Capital Partners LP (the "Partnership"), exchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer.

Footnote F2

Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of the Partnership. Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.

Footnote F3

The pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.